Bicycle Therapeutics plc American Depositary Shares vs. Eli Lilly & Co.
BCYC
Bicycle Therapeutics plc American Depositary Shares
$4.20 -3.00%
VS LLYEli Lilly & Co.
$1174.61 -0.13%
Bicycle Therapeutics plc American Depositary Shares (BCYC) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| BCYC | LLY | |
|---|---|---|
| Market Cap | $303.07 million | $1.05 trillion |
| Revenue (TTM) | — | $79.67 billion |
| Net Income (TTM) | — | $26.71 billion |
LLY leads on 1 of 1 size & scale factors.
Valuation
| BCYC | LLY | |
|---|---|---|
| P/E Ratio | — | 39.43 |
| Price / Book | 0.59 | 30.94 |
| Price / Sales | — | 13.16 |
BCYC leads on 1 of 1 valuation factors.
Profitability
| BCYC | LLY | |
|---|---|---|
| Net Margin | — | 33.53% |
| Return on Equity | — | 78.84% |
BCYC and LLY split the profitability factors evenly.
Dividend
| BCYC | LLY | |
|---|---|---|
| Dividend Yield | — | 0.59% |
| Payout Ratio | — | 23.23 |
BCYC and LLY split the dividend factors evenly.
Risk & Sentiment
| BCYC | LLY | |
|---|---|---|
| Short Interest | 0.00% | 1.29% |
BCYC leads on 1 of 1 risk & sentiment factors.
Dig deeper: BCYC overview, BCYC financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.